BioCanCell Announces Terms of $25 Million Funding Round
23 janv. 2018 08h00 HE
|
BioCanCell Ltd.
JERUSALEM, Jan. 23, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL) (the “Company"), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of...
Shareholders Turn Down Tender Offer to Take BioCanCell Private
28 déc. 2017 09h23 HE
|
BioCanCell Ltd.
JERUSALEM, Dec. 28, 2017 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to...
Investors Initiate Tender Offer to Take BioCanCell Private Ahead of Planned Fundraising Round
11 déc. 2017 16h01 HE
|
BioCanCell Ltd.
JERUSALEM, Dec. 11, 2017 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to...
BioCanCell Announces Updated Results from the Phase 2 Clinical Trial of BC-819 and BCG in Patients with Bladder Cancer
15 nov. 2017 16h01 HE
|
BioCanCell Ltd.
JERUSALEM, Nov. 15, 2017 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to...
BioCanCell Announces Exploration of Funding Round Conditioned on a Going Private Transaction and Business Development Update
30 oct. 2017 07h00 HE
|
BioCancell Ltd.
JERUSALEM, Oct. 30, 2017 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to...
BioCanCell Announces Appointment of Ms. Ruti Alon to Board of Directors
14 août 2017 07h00 HE
|
BioCancell Ltd.
JERUSALEM, Aug. 14, 2017 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to...